Table 1 Septic shock patients’ characteristics (n = 7)
From: Intra-cellular lactate concentration in T lymphocytes from septic shock patients — a pilot study
Age | 73 [65–77] | Documentation of infection | |
Male sex | 4 (57%) | Clinics only | 0 (0%) |
Day 28 mortality | 3 (43%) | Clinics + imaging | 1 (14%) |
Clinics + surgery | 1 (14%) | ||
SAPS II score | 62 [56–65] | ||
SOFA score | 9 [8–12] | Microbiologically proved | 5 (71%) |
Charlson score | 1 [0–3.5] | Gram-negative | 4 (80%) |
Gram-positive | 1 (20%) | ||
Norepinephrine dosage | |||
At day 1 (μg/kg/min) | 0.83 [0.54–1.78] | Lactatemia | |
Day 1 | 2.8 [2.3–3.8] | ||
Mechanical ventilation | 7 (100%) | Day 3 | 1.6 [1.4–1.6] |
Type of admission | Lymphocyte purity | 76.5 [69.2–85.9] | |
Medical | 2 (29%) | CD3 purity | 97.3 [96.6–97.9] |
Surgical | 5 (71%) | ||
CD4 (%) | 72.0 [59.9–80.9] | ||
Type of infection | CD8 (%) | 14.8 [11.0–26.5] | |
Community-acquired | 2 29%) | CD4−/8− (%) | 3.1 [1.8–8.2] |
Nosocomial | 5 (71%) | ||
CD4 (/μL) | 295 [220–413] | ||
Site of infection | Treg (%) | 7.7 [7.3–9.5] | |
Pulmonary | 2 (29%) | ||
Intra-abdominal | 3 (43%) | mHLA-DR (ab/c) | 3079 [2590–4010] |
Urinary | 1 (14%) | ||
Others | 1 (14%) | ||